Official Publications Abivax

Equities

Market Closed - Euronext Paris Other stock markets 11:35:04 2024-05-17 am EDT			5-day change	1st Jan Change
12.92 ^EUR	-0.31%		-3.44%	+31.57%

May. 08	Abivax: four abstracts to be presented on obefazimod	CF
May. 08	Abivax SA Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model At Digestive Disease Week 2024	CI

1st-half-year results	22-09-14	CO
1st-half-year results	22-09-14	CO
Threshold crossings	22-09-13	CO
Threshold crossings	22-09-13	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22-09-12	CO
Corporate officers' Statement -: xercise of Stock Options 4	22-09-11	CO
Threshold crossings	22-09-11	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22-09-11	CO
Threshold crossings	22-09-08	CO
Corporate officers' Statement -: xercise of Stock Options 4	22-09-06	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22-09-04	CO
Transaction note	22-09-01	CO
Monthly statement on voting rights	22-08-30	CO
Changes in management and corporate officers	22-08-15	CO
Monthly statement on voting rights	22-07-30	CO
Monthly statement on voting rights	22-06-29	CO
Monthly statement on voting rights	22-05-30	CO
Monthly statement on voting rights	22-04-29	CO
Transaction note	22-04-27	CO
Monthly statement on voting rights	22-03-30	CO
Monthly statement on voting rights	22-02-27	CO
Monthly statement on voting rights	22-01-30	CO
Provisional calendar	22-01-24	CO